Evaluation of foot functionality in cases of rheumatoid arthritis through the FFI-BR and FHSQ-BR questionnaires: a cross-sectional observational study

通过FFI-BR和FHSQ-BR问卷评估类风湿性关节炎患者的足部功能:一项横断面观察研究

阅读:1

Abstract

BACKGROUND: Rheumatoid arthritis (RA) can affect the feet, thus compromising the patient's gait and autonomy. In this study, we investigated foot disability in RA patients using the Brazilian versions of the Foot Health Status Questionnaire (FHSQ-BR) and Foot Function Index (FFI-BR). DESIGN AND SETTING: Cross-sectional, observational study conducted in a tertiary care hospital. METHODS: Two hundred individuals were studied: 100 with RA and 100 controls. Demographic variables and FFI-BR and FHSQ-BR scores were analyzed. In relation to RA patients, data on medications used and on the following clinical variables were collected: Disease Activity Score-28-ESR; erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) level and rheumatoid factor (RF) level. The groups were compared and the scores and clinical variables were correlated. RESULTS: RA patients' scores in the pain, difficulty and disability domains of the FFI-BR questionnaire were worse (P < 0.0001). The FHSQ-BR showed that there were differences between RA patients and controls in relation to the pain and foot function domains: shoes (P < 0.0001), foot health (P < 0.0001), general health (P=0.0002), physical activity (P < 0.0001), social capacity (P = 0.0006) and vigor (P = 0.01). There were correlations between FFI-BR and DAS-28-ESR scores (rho = 0.45), ESR (rho = 0.27) and CRP (rho = 0.24). According to the FHSQ-BR questionnaire, there was a correlation between DAS-28-ESR and worse foot health (rho = 0.29). CONCLUSION: RA patients' scores in the foot health assessment questionnaires were worse than those of controls. A correlation between inflammatory activity and worse foot function was found.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。